Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1995 Feb;63(2):596–600. doi: 10.1128/iai.63.2.596-600.1995

Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria.

H P Beck 1, I Felger 1, B Genton 1, N Alexander 1, F al-Yaman 1, R F Anders 1, M Alpers 1
PMCID: PMC173038  PMID: 7822028

Abstract

A parasitological and immunological survey was carried out in an area in Papua New Guinea highly endemic for malaria. Two hundred fourteen adult individuals were selected for studies to assess their immune responses against the malaria vaccine candidate ring-infected erythrocyte surface antigen (RESA). Total immunoglobulin G (IgG) antibodies directed against RESA as well as specific IgG1, IgG2, and IgG3 antibodies were determined. Humoral responses directed against RESA were frequent in all IgG subclasses. Only IgG3 responses were found to be age dependent. Total anti-RESA IgG antibodies were not correlated with protection against malaria as measured by parasite prevalence, parasite density, or health center attendance. In contrast, cytophilic antibodies (IgG1 and IgG3) were associated with reduced Plasmodium falciparum prevalence and reduced health center attendance. T-cell proliferation in general was low and very infrequent. No correlation between humoral and cellular immune responses could be found. Parasite density, parasite prevalence, and health center visits tended to be reduced in individuals with good humoral and cell-mediated immune responses.

Full Text

The Full Text of this article is available as a PDF (180.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aikawa M., Torii M., Sjölander A., Berzins K., Perlmann P., Miller L. H. Pf155/RESA antigen is localized in dense granules of Plasmodium falciparum merozoites. Exp Parasitol. 1990 Oct;71(3):326–329. doi: 10.1016/0014-4894(90)90037-d. [DOI] [PubMed] [Google Scholar]
  2. Alpers M. P., al-Yaman F., Beck H. P., Bhatia K. K., Hii J., Lewis D. J., Paru R., Smith T. A. The Malaria Vaccine Epidemiology and Evaluation Project of Papua New Guinea: rationale and baseline studies. P N G Med J. 1992 Dec;35(4):285–297. [PubMed] [Google Scholar]
  3. Beck H. P., Felger I., Kabintik S., Tavul L., Genton B., Alexander N., Bhatia K. K., al-Yaman F., Hii J., Alpers M. Assessment of the humoral and cell-mediated immunity against the Plasmodium falciparum vaccine candidates circumsporozoite protein and SPf66 in adults living in highly endemic malarious areas of Papua New Guinea. Am J Trop Med Hyg. 1994 Sep;51(3):356–364. doi: 10.4269/ajtmh.1994.51.356. [DOI] [PubMed] [Google Scholar]
  4. Berzins K., Perlmann H., Wåhlin B., Ekre H. P., Högh B., Petersen E., Wellde B., Schoenbechler M., Williams J., Chulay J. Passive immunization of Aotus monkeys with human antibodies to the Plasmodium falciparum antigen Pf155/RESA. Infect Immun. 1991 Apr;59(4):1500–1506. doi: 10.1128/iai.59.4.1500-1506.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Björkman A., Perlmann H., Petersen E., Hogh B., Lebbad M., Warsame M., Hanson A. P., Perlmann P. Consecutive determinations of seroreactivities to Pf 155/RESA antigen and to its different repetitive sequences in adult men from a holoendemic area of Liberia. Parasite Immunol. 1990 Mar;12(2):115–123. doi: 10.1111/j.1365-3024.1990.tb00941.x. [DOI] [PubMed] [Google Scholar]
  6. Bouharoun-Tayoun H., Druilhe P. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun. 1992 Apr;60(4):1473–1481. doi: 10.1128/iai.60.4.1473-1481.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chougnet C., Deloron P., Lepers J. P., Tallet S., Rason M. D., Astagneau P., Savel J., Coulanges P. Humoral and cell-mediated immune responses to the Plasmodium falciparum antigens PF155/RESA and CS protein: seasonal variations in a population recently reexposed to endemic malaria. Am J Trop Med Hyg. 1990 Sep;43(3):234–242. doi: 10.4269/ajtmh.1990.43.234. [DOI] [PubMed] [Google Scholar]
  8. Collins W. E., Anders R. F., Pappaioanou M., Campbell G. H., Brown G. V., Kemp D. J., Coppel R. L., Skinner J. C., Andrysiak P. M., Favaloro J. M. Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum. Nature. 1986 Sep 18;323(6085):259–262. doi: 10.1038/323259a0. [DOI] [PubMed] [Google Scholar]
  9. Collins W. E., Anders R. F., Ruebush T. K., 2nd, Kemp D. J., Woodrow G. C., Campbell G. H., Brown G. V., Irving D. O., Goss N., Filipski V. K. Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum. Am J Trop Med Hyg. 1991 Jan;44(1):34–41. doi: 10.4269/ajtmh.1991.44.34. [DOI] [PubMed] [Google Scholar]
  10. Culvenor J. G., Day K. P., Anders R. F. Plasmodium falciparum ring-infected erythrocyte surface antigen is released from merozoite dense granules after erythrocyte invasion. Infect Immun. 1991 Mar;59(3):1183–1187. doi: 10.1128/iai.59.3.1183-1187.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Davignon J. L., Vallin-Davignon M., Cohen P. L., Eisenberg R. A. Targeting of T-B interaction using heteroconjugate antibody. Immunology. 1991 May;73(1):1–7. [PMC free article] [PubMed] [Google Scholar]
  12. Desowitz R. S. Plasmodium-specific immunoglobulin E in sera from an area of holoendemic malaria. Trans R Soc Trop Med Hyg. 1989 Jul-Aug;83(4):478–479. doi: 10.1016/0035-9203(89)90254-x. [DOI] [PubMed] [Google Scholar]
  13. Doolan D. L., Khamboonruang C., Beck H. P., Houghten R. A., Good M. F. Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants. Int Immunol. 1993 Jan;5(1):37–46. doi: 10.1093/intimm/5.1.37. [DOI] [PubMed] [Google Scholar]
  14. Dubois B., Deloron P., Astagneau P., Chougnet C., Lepers J. P. Isotypic analysis of Plasmodium falciparum-specific antibodies and their relation to protection in Madagascar. Infect Immun. 1993 Oct;61(10):4498–4500. doi: 10.1128/iai.61.10.4498-4500.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Falanga P. B., D'Imperio Lima M. R., Coutinho A., Pereira da Silva L. Isotypic pattern of the polyclonal B cell response during primary infection by Plasmodium chabaudi and in immune-protected mice. Eur J Immunol. 1987 May;17(5):599–603. doi: 10.1002/eji.1830170504. [DOI] [PubMed] [Google Scholar]
  16. Ho M., Webster H. K. T cell responses in acute falciparum malaria. Immunol Lett. 1990 Aug;25(1-3):135–138. doi: 10.1016/0165-2478(90)90104-x. [DOI] [PubMed] [Google Scholar]
  17. Kabilan L., Troye-Blomberg M., Perlmann H., Andersson G., Högh B., Petersen E., Björkman A., Perlmann P. T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine. Proc Natl Acad Sci U S A. 1988 Aug;85(15):5659–5663. doi: 10.1073/pnas.85.15.5659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kansas G. S., Cambier J. C., Tedder T. F. CD4 binding to major histocompatibility complex class II antigens induces LFA-1-dependent and -independent homotypic adhesion of B lymphocytes. Eur J Immunol. 1992 Jan;22(1):147–152. doi: 10.1002/eji.1830220122. [DOI] [PubMed] [Google Scholar]
  19. Mvondo J. L., James M. A., Sulzer A. J., Campbell C. C. Malaria and pregnancy in Cameroonian women. Naturally acquired antibody responses to asexual blood-stage antigens and the circumsporozoite protein of Plasmodium falciparum. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):486–490. doi: 10.1016/0035-9203(92)90080-v. [DOI] [PubMed] [Google Scholar]
  20. Perlmann H. K., Berzins K., Wåhlin B., Udomsangpetch R., Ruangjirachuporn W., Wahlgren M., Perlmann P. H. Absence of antigenic diversity in Pf155, a major parasite antigen in membranes of erythrocytes infected with Plasmodium falciparum. J Clin Microbiol. 1987 Dec;25(12):2347–2354. doi: 10.1128/jcm.25.12.2347-2354.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Petersen E., Høgh B., Perlmann H., Kabilan L., Troye-Blomberg M., Marbiah N. T., Hanson A. P., Björkman A., Perlmann P. An epidemiological study of humoral and cell-mediated immune response to the Plasmodium falciparum antigen PF155/RESA in adult Liberians. Am J Trop Med Hyg. 1989 Oct;41(4):386–394. doi: 10.4269/ajtmh.1989.41.386. [DOI] [PubMed] [Google Scholar]
  22. Pye D., Edwards S. J., Anders R. F., O'Brien C. M., Franchina P., Corcoran L. N., Monger C., Peterson M. G., Vandenberg K. L., Smythe J. A. Failure of recombinant vaccinia viruses expressing Plasmodium falciparum antigens to protect Saimiri monkeys against malaria. Infect Immun. 1991 Jul;59(7):2403–2411. doi: 10.1128/iai.59.7.2403-2411.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Riley E. M., Allen S. J., Troye-Blomberg M., Bennett S., Perlmann H., Andersson G., Smedman L., Perlmann P., Greenwood B. M. Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: a prospective study in a malaria-endemic region of west Africa. Trans R Soc Trop Med Hyg. 1991 Jul-Aug;85(4):436–443. doi: 10.1016/0035-9203(91)90207-f. [DOI] [PubMed] [Google Scholar]
  24. Rzepczyk C. M., Ramasamy R., Ho P. C., Mutch D. A., Anderson K. L., Duggleby R. G., Doran T. J., Murray B. J., Irving D. O., Woodrow G. C. Identification of T epitopes within a potential Plasmodium falciparum vaccine antigen. A study of human lymphocyte responses to repeat and nonrepeat regions of Pf155/RESA. J Immunol. 1988 Nov 1;141(9):3197–3202. [PubMed] [Google Scholar]
  25. Snapper C. M., McIntyre T. M., Mandler R., Pecanha L. M., Finkelman F. D., Lees A., Mond J. J. Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med. 1992 May 1;175(5):1367–1371. doi: 10.1084/jem.175.5.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Troye-Blomberg M., Olerup O., Larsson A., Sjöberg K., Perlmann H., Riley E., Lepers J. P., Perlmann P. Failure to detect MHC class II associations of the human immune response induced by repeated malaria infections to the Plasmodium falciparum antigen Pf155/RESA. Int Immunol. 1991 Oct;3(10):1043–1051. doi: 10.1093/intimm/3.10.1043. [DOI] [PubMed] [Google Scholar]
  27. Troye-Blomberg M., Riley E. M., Perlmann H., Andersson G., Larsson A., Snow R. W., Allen S. J., Houghten R. A., Olerup O., Greenwood B. M. T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. J Immunol. 1989 Nov 1;143(9):3043–3048. [PubMed] [Google Scholar]
  28. Wahlgren M., Berzins K., Perlmann P., Persson M. Characterization of the humoral immune response in Plasmodium falciparum malaria. II. IgG subclass levels of anti-P. falciparum antibodies in different sera. Clin Exp Immunol. 1983 Oct;54(1):135–142. [PMC free article] [PubMed] [Google Scholar]
  29. Wahlgren M., Björkman A., Perlmann H., Berzins K., Perlmann P. Anti-Plasmodium falciparum antibodies acquired by residents in a holoendemic area of Liberia during development of clinical immunity. Am J Trop Med Hyg. 1986 Jan;35(1):22–29. doi: 10.4269/ajtmh.1986.35.22. [DOI] [PubMed] [Google Scholar]
  30. Warsame M., Perlmann H., Ali S., Hagi H., Farah S., Lebbad M., Björkman A. The seroreactivity against Pf155 (RESA) antigen in villagers from a mesoendemic area in Somalia. Trop Med Parasitol. 1989 Dec;40(4):412–414. [PubMed] [Google Scholar]
  31. Wåhlin B., Wahlgren M., Perlmann H., Berzins K., Björkman A., Patarroyo M. E., Perlmann P. Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7912–7916. doi: 10.1073/pnas.81.24.7912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. ten Hagen T. L., Sulzer A. J., Kidd M. R., Lal A. A., Hunter R. L. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines. J Immunol. 1993 Dec 15;151(12):7077–7085. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES